Wandercraft has produced a walking assist powered exoskeleton that has just received FDA approval in the US to treat stroke patients. The excoskeleton is a self-balancing, battery-powered device that can help intensive patients with gait training, especially for those with upper body limitations.
Wandercraft plans to deliver its first exoskeletons to the US during the first quarter of 2023.
Click here to read the entire article.